According to filings with the U.S. Securities and Exchange Commission, Mytos is raising $18,008,172.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ali Afshar played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Mytos
Mytos automates one of the last highly manual processes in biotech – growing human cells. Our products help teams in drug development and cell therapy save time while increasing the reproducibility of their data. Mytos is backed by a fleet of leading investors including YCombinator. Our team is made up of brilliant engineers from Dyson, Formlabs and Cambridge Consultants and driven scientists who have worked in top labs including at Imperial College, University of Cambridge and UCL. Were hiring now- visit our website to see open positions.

To learn more about Mytos, visit https://www.mytos.bio/

Contact:
Ali Afshar, Chief Executive Officer
650-695-7972
https://www.linkedin.com/in/ali-afshar-0246002b/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.